Corrigendum to “Rationale and design of the HOME trial: A pragmatic randomized controlled trial of home-based human papillomavirus (HPV) self-sampling for increasing cervical cancer screening uptake and effectiveness in a U.S. healthcare system” (Contemporary Clinical Trials (2018) 64 (77–87), (S1551714417304536), (10.1016/j.cct.2017.11.004))

Rachel L. Winer, Jasmin A. Tiro, Diana L Miglioretti, C. Thayer, Tara Beatty, John Lin, Hongyuan Gao, Kilian Kimbel, Diana S.M. Buist

Research output: Contribution to journalComment/debate

Abstract

In the abstract, we erroneously indicated that our definition of cervical cancer under-screening was “≥3.4 years since last Pap,” instead of >3.4 years since last Pap. We also reported incorrect numbers of women who were invited to complete and completed interviews and surveys. In Section 2.7, we indicated that interview invitations were mailed to 58 HPV positive women who completed recommended follow-up and 16 HPV positive women who did not complete follow-up; the correct numbers are 62 invitations mailed to women who completed follow-up and 13 women who did not. In Section 2.7 and Fig. 1 we further reported 34 completed interviews in women who completed follow-up and 12 in women who did not; the correct numbers are 38 interviews in women who completed follow-up and in women 8 who did not. In Section 2.8, we indicated that survey invitations were mailed to 1055 HPV kit non-returners; the correct number is 1083. In Section 2.8 and Fig. 1, we indicated that 118 surveys were received from kit returners and 116 from kit non-returners; the correct numbers are 116 from kit returners and 119 from non-returners (235 total). We regret any confusion caused by these errors.

Original languageEnglish (US)
Article number105811
JournalContemporary Clinical Trials
DOIs
StatePublished - Jan 1 2019

Fingerprint

Pragmatic Clinical Trials
Early Detection of Cancer
Uterine Cervical Neoplasms
Randomized Controlled Trials
Clinical Trials
Delivery of Health Care
Interviews
corrigendum
Confusion
Human papillomavirus 16
Emotions

ASJC Scopus subject areas

  • Pharmacology (medical)

Cite this

@article{60d6dbb763274d2c8db213dbb419d33c,
title = "Corrigendum to “Rationale and design of the HOME trial: A pragmatic randomized controlled trial of home-based human papillomavirus (HPV) self-sampling for increasing cervical cancer screening uptake and effectiveness in a U.S. healthcare system” (Contemporary Clinical Trials (2018) 64 (77–87), (S1551714417304536), (10.1016/j.cct.2017.11.004))",
abstract = "In the abstract, we erroneously indicated that our definition of cervical cancer under-screening was “≥3.4 years since last Pap,” instead of >3.4 years since last Pap. We also reported incorrect numbers of women who were invited to complete and completed interviews and surveys. In Section 2.7, we indicated that interview invitations were mailed to 58 HPV positive women who completed recommended follow-up and 16 HPV positive women who did not complete follow-up; the correct numbers are 62 invitations mailed to women who completed follow-up and 13 women who did not. In Section 2.7 and Fig. 1 we further reported 34 completed interviews in women who completed follow-up and 12 in women who did not; the correct numbers are 38 interviews in women who completed follow-up and in women 8 who did not. In Section 2.8, we indicated that survey invitations were mailed to 1055 HPV kit non-returners; the correct number is 1083. In Section 2.8 and Fig. 1, we indicated that 118 surveys were received from kit returners and 116 from kit non-returners; the correct numbers are 116 from kit returners and 119 from non-returners (235 total). We regret any confusion caused by these errors.",
author = "Winer, {Rachel L.} and Tiro, {Jasmin A.} and Miglioretti, {Diana L} and C. Thayer and Tara Beatty and John Lin and Hongyuan Gao and Kilian Kimbel and Buist, {Diana S.M.}",
year = "2019",
month = "1",
day = "1",
doi = "10.1016/j.cct.2019.07.003",
language = "English (US)",
journal = "Contemporary Clinical Trials",
issn = "1551-7144",
publisher = "Elsevier Inc.",

}

TY - JOUR

T1 - Corrigendum to “Rationale and design of the HOME trial

T2 - A pragmatic randomized controlled trial of home-based human papillomavirus (HPV) self-sampling for increasing cervical cancer screening uptake and effectiveness in a U.S. healthcare system” (Contemporary Clinical Trials (2018) 64 (77–87), (S1551714417304536), (10.1016/j.cct.2017.11.004))

AU - Winer, Rachel L.

AU - Tiro, Jasmin A.

AU - Miglioretti, Diana L

AU - Thayer, C.

AU - Beatty, Tara

AU - Lin, John

AU - Gao, Hongyuan

AU - Kimbel, Kilian

AU - Buist, Diana S.M.

PY - 2019/1/1

Y1 - 2019/1/1

N2 - In the abstract, we erroneously indicated that our definition of cervical cancer under-screening was “≥3.4 years since last Pap,” instead of >3.4 years since last Pap. We also reported incorrect numbers of women who were invited to complete and completed interviews and surveys. In Section 2.7, we indicated that interview invitations were mailed to 58 HPV positive women who completed recommended follow-up and 16 HPV positive women who did not complete follow-up; the correct numbers are 62 invitations mailed to women who completed follow-up and 13 women who did not. In Section 2.7 and Fig. 1 we further reported 34 completed interviews in women who completed follow-up and 12 in women who did not; the correct numbers are 38 interviews in women who completed follow-up and in women 8 who did not. In Section 2.8, we indicated that survey invitations were mailed to 1055 HPV kit non-returners; the correct number is 1083. In Section 2.8 and Fig. 1, we indicated that 118 surveys were received from kit returners and 116 from kit non-returners; the correct numbers are 116 from kit returners and 119 from non-returners (235 total). We regret any confusion caused by these errors.

AB - In the abstract, we erroneously indicated that our definition of cervical cancer under-screening was “≥3.4 years since last Pap,” instead of >3.4 years since last Pap. We also reported incorrect numbers of women who were invited to complete and completed interviews and surveys. In Section 2.7, we indicated that interview invitations were mailed to 58 HPV positive women who completed recommended follow-up and 16 HPV positive women who did not complete follow-up; the correct numbers are 62 invitations mailed to women who completed follow-up and 13 women who did not. In Section 2.7 and Fig. 1 we further reported 34 completed interviews in women who completed follow-up and 12 in women who did not; the correct numbers are 38 interviews in women who completed follow-up and in women 8 who did not. In Section 2.8, we indicated that survey invitations were mailed to 1055 HPV kit non-returners; the correct number is 1083. In Section 2.8 and Fig. 1, we indicated that 118 surveys were received from kit returners and 116 from kit non-returners; the correct numbers are 116 from kit returners and 119 from non-returners (235 total). We regret any confusion caused by these errors.

UR - http://www.scopus.com/inward/record.url?scp=85068795479&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85068795479&partnerID=8YFLogxK

U2 - 10.1016/j.cct.2019.07.003

DO - 10.1016/j.cct.2019.07.003

M3 - Comment/debate

AN - SCOPUS:85068795479

JO - Contemporary Clinical Trials

JF - Contemporary Clinical Trials

SN - 1551-7144

M1 - 105811

ER -